So are you buying at these prices? Also if you are when do you...

First 15 Last

Share
Profile

Follow
Solarpat

323 Posts.

15

05/02/19

22:43

Post #: 37342081
Share

Originally posted by TradeX8: ↑

I STILL BELIEVE they are being PAID FAR to much for the results they are achieving and I have made myself very clear on here and DIRECTLY to the board of directors via the CEO.

Domenic knows exactly how I feel and considering I have a few shares and I can also write a few words on here IMO they have listened and are addressing directors fees.

There will be a six monthly update this month as indicated by the company and shareholders will certainly be advised then I am sure of all the cost cuttings the company has undertaken.

If then shareholders still believe adjustments need to be made I am sure it will be reflected in the share price.

Apart from excessive directors fees I am happy to see the new division unfold. My sentiment for the company has not changed my sentiment for the directors fees has not changed.

They are viewed separately and not put in to the one basket.

What I wrote on this forum previously has certainly been read by the CEO of Crowd Media about the directors fees.

I support their efforts in building this company I dont support the excessive directors fees.

I hope that clears up any misunderstandings you may have.

I still feel the shares are very cheap at these levels based on the revenues of the company, the client base and the potential of the new division.

Expand

So are you buying at these prices? Also if you are when do you think the turn around will come as my patients is pretty thin .

CM8 Price at posting: 2.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 19 more messages in this thread...

First 15 Last

Add CM8 (ASX) to my watchlist

So are you buying at these prices? Also if you are when do you...

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher